Literature DB >> 25732734

WEE1 is a validated target of the microRNA miR-17-92 cluster in leukemia.

Sonia Brockway1, Nancy J Zeleznik-Le2.   

Abstract

MicroRNAs are short single-stranded RNAs that regulate target gene expression by binding to complementary sites in the 3' untranslated region (UTR) of their mRNA targets. The polycistronic miR-17-92 cluster, which encodes miR-17, miR-18a, miR-19a, miR-20a, miR-19b, and miR-92a, was previously shown to be overexpressed in multiple types of cancer. In this study, target gene prediction algorithms were used to predict potential targets of the miR-17-92 cluster. WEE1, a kinase that inhibits cell cycle progression, was identified as a possible target of five of the six miRNAs in the cluster. Luciferase reporter assays were used to determine that miR-17, miR-20a, and miR-18a specifically target nucleotides 465-487 of the 3' UTR of WEE1, whereas miR-19a and miR-19b exert control on WEE1 by targeting nucleotides 1069-1091. A negative correlation was determined between endogenous miR-17 or miR-19a expression and endogenous WEE1 protein expression in the same panel of cell lines. We conclude that WEE1 is a valid target of the miR-17-92 cluster in leukemia.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MicroRNA; WEE1; kinase; leukemia; miR-17-92

Mesh:

Substances:

Year:  2015        PMID: 25732734      PMCID: PMC4466047          DOI: 10.1016/j.cancergen.2015.01.001

Source DB:  PubMed          Journal:  Cancer Genet


  29 in total

Review 1.  Expression profiling of microRNA using real-time quantitative PCR, how to use it and what is available.

Authors:  Vladimir Benes; Mirco Castoldi
Journal:  Methods       Date:  2010-01-28       Impact factor: 3.608

2.  CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo.

Authors:  Leena Chaudhuri; Nicole D Vincelette; Brian D Koh; Ryan M Naylor; Karen S Flatten; Kevin L Peterson; Amanda McNally; Ivana Gojo; Judith E Karp; Ruben A Mesa; Lisa O Sproat; James M Bogenberger; Scott H Kaufmann; Raoul Tibes
Journal:  Haematologica       Date:  2013-10-31       Impact factor: 9.941

3.  The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice.

Authors:  Yanmei Li; Laura M Vecchiarelli-Federico; You-Jun Li; Sean E Egan; David Spaner; Margaret R Hough; Yaacov Ben-David
Journal:  Blood       Date:  2012-03-26       Impact factor: 22.113

4.  An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans.

Authors:  N C Lau; L P Lim; E G Weinstein; D P Bartel
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

5.  Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia.

Authors:  Shuangli Mi; Zejuan Li; Ping Chen; Chunjiang He; Donglin Cao; Abdel Elkahloun; Jun Lu; Luis A Pelloso; Mark Wunderlich; Hao Huang; Roger T Luo; Miao Sun; Miao He; Mary Beth Neilly; Nancy J Zeleznik-Le; Michael J Thirman; James C Mulloy; Paul P Liu; Janet D Rowley; Jianjun Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

Review 6.  miRiad roles for the miR-17-92 cluster in development and disease.

Authors:  Joshua T Mendell
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

7.  Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes.

Authors:  Changchun Xiao; Lakshmi Srinivasan; Dinis Pedro Calado; Heide Christine Patterson; Baochun Zhang; Jing Wang; Joel M Henderson; Jeffrey L Kutok; Klaus Rajewsky
Journal:  Nat Immunol       Date:  2008-03-09       Impact factor: 25.606

8.  Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia.

Authors:  C C Porter; J Kim; S Fosmire; C M Gearheart; A van Linden; D Baturin; V Zaberezhnyy; P R Patel; D Gao; A C Tan; J DeGregori
Journal:  Leukemia       Date:  2012-01-13       Impact factor: 11.528

9.  CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells.

Authors:  Wenxiu Qi; Chengzhi Xie; Chunhuai Li; J Timothy Caldwell; Holly Edwards; Jeffrey W Taub; Yue Wang; Hai Lin; Yubin Ge
Journal:  J Hematol Oncol       Date:  2014-08-01       Impact factor: 17.388

10.  A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations.

Authors:  L Zhou; Y Zhang; S Chen; M Kmieciak; Y Leng; H Lin; K A Rizzo; C I Dumur; A Ferreira-Gonzalez; Y Dai; S Grant
Journal:  Leukemia       Date:  2014-10-06       Impact factor: 11.528

View more
  8 in total

Review 1.  Good or not good: Role of miR-18a in cancer biology.

Authors:  Tomasz Kolenda; Kacper Guglas; Magda Kopczyńska; Joanna Sobocińska; Anna Teresiak; Renata Bliźniak; Katarzyna Lamperska
Journal:  Rep Pract Oncol Radiother       Date:  2020-08-12

2.  [Value of serum miR-17-92 cluster in diagnosis of retinoblastoma].

Authors:  Yan-Zhao Chen; Zhi-Ping Liu; Ke-Ying Zhou; Bo Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-07

3.  Association between MicroRNA-373 and Long Noncoding RNA NORAD in Hepatitis C Virus-Infected Hepatocytes Impairs Wee1 Expression for Growth Promotion.

Authors:  Subhayan Sur; Reina Sasaki; Pradip Devhare; Robert Steele; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

Review 4.  The roles of microRNAs in Wilms' tumors.

Authors:  Xin Yu; Zheng Li; Matthew T V Chan; William Ka Kei Wu
Journal:  Tumour Biol       Date:  2015-12-03

Review 5.  Role of MicroRNAs in Human Osteosarcoma: Future Perspectives.

Authors:  Lola Llobat; Olivia Gourbault
Journal:  Biomedicines       Date:  2021-04-23

6.  Prediction of competing endogenous RNA coexpression network as prognostic markers in AML.

Authors:  Jun-Dan Wang; Hong-Sheng Zhou; Xi-Xiang Tu; Yi He; Qi-Fa Liu; Quentin Liu; Zi-Jie Long
Journal:  Aging (Albany NY)       Date:  2019-05-31       Impact factor: 5.682

Review 7.  Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes.

Authors:  Celestino Sardu; Michelangela Barbieri; Maria Rosaria Rizzo; Pasquale Paolisso; Giuseppe Paolisso; Raffaele Marfella
Journal:  J Diabetes Res       Date:  2015-11-09       Impact factor: 4.011

Review 8.  The emerging role of miR-19 in glioma.

Authors:  Weihan Wang; Anling Zhang; Yubing Hao; Guangxiu Wang; Zhifan Jia
Journal:  J Cell Mol Med       Date:  2018-08-02       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.